Investing.com - Bio-Techne (NASDAQ: TECH) reported first quarter EPS of $0.53, in line with the analyst estimate of $0.53. Revenue for the quarter came in at $294.1M versus the consensus estimate of $296.61M.
Bio-Techne's stock price closed at $80.20. It is up 1.31% in the last 3 months and down -18.96% in the last 12 months.
Bio-Techne saw 0 positive EPS revisions and 11 negative EPS revisions in the last 90 days. See Bio-Techne's stock price’s past reactions to earnings here.
According to InvestingPro, Bio-Techne's Financial Health score is "great performance".
Check out Bio-Techne's recent earnings performance, and Bio-Techne's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar